Praxis Precision Medicines Stock Performance
| PRAX Stock | USD 335.28 3.67 1.11% |
Praxis Precision holds a performance score of 15 on a scale of zero to a hundred. The company holds a Beta of -0.22, which implies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Praxis Precision are expected to decrease at a much lower rate. During the bear market, Praxis Precision is likely to outperform the market. Use Praxis Precision potential upside, and the relationship between the jensen alpha and accumulation distribution , to analyze future returns on Praxis Precision.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Praxis Precision Medicines are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain basic indicators, Praxis Precision showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 1.11 | Five Day Return 6.36 | Year To Date Return 17.07 | Ten Year Return (19.60) | All Time Return (19.60) |
Last Split Factor 1:15 | Last Split Date 2023-11-29 |
1 | TD Cowen Lifts Praxis Precision Medicines Inc. Price Target amid NDA for Essential Tremor Treatment | 12/11/2025 |
2 | Disposition of 405 shares by Souza Marcio of Praxis Precision at 292.63 subject to Rule 16b-3 | 01/07/2026 |
3 | Insider Trading | 01/08/2026 |
4 | Disposition of 4252 shares by Souza Marcio of Praxis Precision at 288.45 subject to Rule 16b-3 | 01/09/2026 |
5 | Why Praxis Precision Medicines Is Up 5.1 percent After Dual NDA Plans And Data Platform Expansion | 02/03/2026 |
6 | Is Praxis Precision Medicines Now Pricing In Recent Pipeline Progress And Volatile Share Gains | 02/05/2026 |
7 | Acquisition by Kindler Jeffrey B of 224 shares of Praxis Precision at 319.57 subject to Rule 16b-3 | 02/06/2026 |
8 | Praxis Precision Medicines to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 19, 2026, and Participate in Upcoming Investor Co... | 02/09/2026 |
9 | Profund Advisors LLC Raises Stake in Praxis Precision Medicines, Inc. PRAX | 02/13/2026 |
10 | Earnings Outlook For Praxis Precision Medicine | 02/18/2026 |
11 | Praxis Precision Medicines Inc Q4 2025 Earnings Call Highlights Strong Financial ... | 02/19/2026 |
12 | Praxis Precision Medicine Analysts Raise Their Forecasts After Q4 Results | 02/20/2026 |
| Begin Period Cash Flow | 215.8 M | |
| Total Cashflows From Investing Activities | -311.1 M |
Praxis Precision Relative Risk vs. Return Landscape
If you would invest 19,086 in Praxis Precision Medicines on November 24, 2025 and sell it today you would earn a total of 14,442 from holding Praxis Precision Medicines or generate 75.67% return on investment over 90 days. Praxis Precision Medicines is currently generating 1.0518% in daily expected returns and assumes 5.2811% risk (volatility on return distribution) over the 90 days horizon. In different words, 47% of stocks are less volatile than Praxis, and 79% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Praxis Precision Target Price Odds to finish over Current Price
The tendency of Praxis Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 335.28 | 90 days | 335.28 | about 10.55 |
Based on a normal probability distribution, the odds of Praxis Precision to move above the current price in 90 days from now is about 10.55 (This Praxis Precision Medicines probability density function shows the probability of Praxis Stock to fall within a particular range of prices over 90 days) .
Praxis Precision Price Density |
| Price |
Predictive Modules for Praxis Precision
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Praxis Precision Med. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Praxis Precision Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Praxis Precision is not an exception. The market had few large corrections towards the Praxis Precision's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Praxis Precision Medicines, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Praxis Precision within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 1.05 | |
β | Beta against Dow Jones | -0.22 | |
σ | Overall volatility | 50.15 | |
Ir | Information ratio | 0.17 |
Praxis Precision Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Praxis Precision for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Praxis Precision Med can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Praxis Precision Med is way too risky over 90 days horizon | |
| Praxis Precision Med appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 7.46 M. Net Loss for the year was (303.27 M) with loss before overhead, payroll, taxes, and interest of (238.43 M). | |
| Praxis Precision Medicines currently holds about 165.4 M in cash with (249.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.7. | |
| Praxis Precision Med has a frail financial position based on the latest SEC disclosures | |
| Over 100.0% of the company shares are owned by institutional investors | |
| Latest headline from benzinga.com: Praxis Precision Medicine Analysts Raise Their Forecasts After Q4 Results |
Praxis Precision Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Praxis Stock often depends not only on the future outlook of the current and potential Praxis Precision's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Praxis Precision's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 22.5 M | |
| Cash And Short Term Investments | 599.3 M |
Praxis Precision Fundamentals Growth
Praxis Stock prices reflect investors' perceptions of the future prospects and financial health of Praxis Precision, and Praxis Precision fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Praxis Stock performance.
| Return On Equity | -0.75 | ||||
| Return On Asset | -0.45 | ||||
| Operating Margin | (39.28) % | ||||
| Current Valuation | 9.03 B | ||||
| Shares Outstanding | 27.74 M | ||||
| Price To Book | 27.07 X | ||||
| Price To Sales | 1,246 X | ||||
| Revenue | 7.46 M | ||||
| Gross Profit | (238.43 M) | ||||
| EBITDA | (326.2 M) | ||||
| Net Income | (303.27 M) | ||||
| Cash And Equivalents | 165.4 M | ||||
| Cash Per Share | 3.70 X | ||||
| Total Debt | 110 K | ||||
| Debt To Equity | 0.03 % | ||||
| Current Ratio | 4.56 X | ||||
| Book Value Per Share | 16.23 X | ||||
| Cash Flow From Operations | (249.07 M) | ||||
| Earnings Per Share | (12.98) X | ||||
| Market Capitalization | 9.3 B | ||||
| Total Asset | 937.91 M | ||||
| Retained Earnings | (1.14 B) | ||||
| Working Capital | 366.82 M | ||||
About Praxis Precision Performance
Evaluating Praxis Precision's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Praxis Precision has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Praxis Precision has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.32) | (0.34) | |
| Return On Capital Employed | (0.37) | (0.39) | |
| Return On Assets | (0.32) | (0.34) | |
| Return On Equity | (0.35) | (0.36) |
Things to note about Praxis Precision Med performance evaluation
Checking the ongoing alerts about Praxis Precision for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Praxis Precision Med help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Praxis Precision Med is way too risky over 90 days horizon | |
| Praxis Precision Med appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 7.46 M. Net Loss for the year was (303.27 M) with loss before overhead, payroll, taxes, and interest of (238.43 M). | |
| Praxis Precision Medicines currently holds about 165.4 M in cash with (249.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.7. | |
| Praxis Precision Med has a frail financial position based on the latest SEC disclosures | |
| Over 100.0% of the company shares are owned by institutional investors | |
| Latest headline from benzinga.com: Praxis Precision Medicine Analysts Raise Their Forecasts After Q4 Results |
- Analyzing Praxis Precision's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Praxis Precision's stock is overvalued or undervalued compared to its peers.
- Examining Praxis Precision's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Praxis Precision's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Praxis Precision's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Praxis Precision's stock. These opinions can provide insight into Praxis Precision's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Praxis Stock Analysis
When running Praxis Precision's price analysis, check to measure Praxis Precision's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Praxis Precision is operating at the current time. Most of Praxis Precision's value examination focuses on studying past and present price action to predict the probability of Praxis Precision's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Praxis Precision's price. Additionally, you may evaluate how the addition of Praxis Precision to your portfolios can decrease your overall portfolio volatility.